NEW YORK (GenomeWeb) – Canadian firm LexaGene Holdings said today that it has closed a non-brokered private placement under which it raised gross proceeds of about C$2 million ($1.5 million).

The company sold 6.7 million units of common stock at C$.30 per unit. Each unit consisted of one common share and one common share purchase warrant, which entitles the holder to acquire an additional common share for C$.60 per share within a three-year period. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.